Choledocholithiasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients over 18 years old with clinically diagnosed choledocholithiasis and planned to undergo surgery; 2. The distal diameter of the common bile duct is greater than or equal to 10mm; 3. Diameter of choledocholithiasis 10-15mm; 4. With the approval of the medical Ethics Committee, the patient and his family members will voluntarily sign the informed consent; 5. No serious systemic diseases. 6. Complete clinical data.
Exclusion criteria
Exclusion criteria: 1. Patients with coagulation dysfunction (international normalized ratio >1.3) and thrombocytopenia (platelet count <50×10? cells per liter) who have taken anticoagulant or antiplatelet drugs in the last 3 days; 2. Previous history of gastrointestinal reconstructive surgery, such as Bi II gastrectomy, gastrointestinal Roux-en-Y anastomosis, pancreaticoduodenectomy; 3. History of EST or EPBD before the surgery; 4. And pre-existing conditions, such as acute pancreatitis, gastrointestinal bleeding, severe liver disease, primary sclerosing cholangitis, cholangitis with septic shock; 5. Known Mirizzi syndrome or intrahepatic bile duct calculus or cholestroduodenal fistula; 6. Pregnant women and lactation period; 7. Common bile duct intubation failed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of Oddi sphincter dysfunction (cholangitis, choledocholithiasis recurrence); | — |
Secondary
| Measure | Time frame |
|---|---|
| Success rate of stone removal during ERCP surgery;Incidence of postoperative gastrointestinal bleeding, duodenal perforation, and acute pancreatitis;operative time; | — |
Countries
China
Contacts
Xiangyang Central Hospital